EP Patent

EP1581213A4 — 3,5-DISUBSTITUES-1,2,4-OXADIAZOLES AND ANALOGS AS ACTIVATORS OF CASPASES AND APOPTOSIS PROMOTERS, AND USE THEREOF

Assigned to Cytovia Therapeutics LLC · Expires 2008-11-19 · 17y expired

What this patent protects

Patent listed against Vidaza.

Drugs covered by this patent

Patent Metadata

Patent number
EP1581213A4
Jurisdiction
EP
Classification
—
Expires
2008-11-19
Drug substance claim
No
Drug product claim
No
Assignee
Cytovia Therapeutics LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.